Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Proellex

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Telapristone (CDB-4124 or Proellex®) is a PRM (progesterone antagonist) under development for treatment of uterine… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2013
2013
Aromatase inhibitors (AI) are considered as a first line therapy for ER+PR+ breast cancers. However, many patients acquire… Expand
2011
2011
CDB-4124 (Proellex or telapristone acetate) is a modulator of progesterone receptor (PR) signaling, which is currently employed… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 6
2011
2011
  • N. Sarkar
  • German medical science : GMS e-journal
  • 2011
  • Corpus ID: 13557711
The objective of this study is to evaluate and elucidated the potential of selective progesterone receptor modulators (SPRMs) to… Expand
2010
2010
CDB-4124 (Proellex or Telapristone acetate) is a modulator of progesterone receptor (PR) signaling which has been employed in… Expand
Review
2009
Review
2009
  • I. Spitz
  • Current opinion in obstetrics & gynecology
  • 2009
  • Corpus ID: 2121292
Purpose of review In view of the spate of recent publications related to mifepristone and some second generation progesterone… Expand
Review
2008
Review
2008
Background: A large number of synthetic compounds known as selective progesterone receptor modulators can bind to progesterone… Expand
Review
2008
Review
2008
Background: Synthetic compounds can bind to progesterone receptors and these progesterone receptor ligands exhibit a spectrum of… Expand
Review
2008
Review
2008
BACKGROUND A large number of synthetic compounds known as selective progesterone receptor modulators can bind to progesterone… Expand
Review
2008
Review
2008
Background: A number of synthetic steroids are capable of modulating progesterone receptors with a spectrum of activities ranging… Expand